About: Agnès Veyradier

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Agnès Veyradier Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) chercheuse (fr) investigadora (es) araştırmacı (tr) дослідник (uk) հետազոտող (hy) researcher (en-ca) researcher (en-gb) researcher (en-us) ricercatrice (it) investigadora (ca) investigadora (gl) investigadora (pt) hematoloog (nl) investigadora (ast)
rdfs:label	Agnès Veyradier (en) Agnès Veyradier (es) Agnès Veyradier (fr) Agnès Veyradier (nl) Agnès Veyradier (ast)
skos:prefLabel	Agnès Veyradier (en) Agnès Veyradier (es) Agnès Veyradier (fr) Agnès Veyradier (nl) Agnès Veyradier (ast)
name	Agnès Veyradier (en) Agnès Veyradier (es) Agnès Veyradier (fr) Agnès Veyradier (nl) Agnès Veyradier (ast)
LinkedIn personal profile ID	wds:Q42224319-C93D5E0B-4F7E-424F-8894-4E9973A782CD
LinkedIn personal profile ID	agnès-veyradier-ba0507121
given name	wds:Q42224319-13E633AA-0CF2-47A2-9995-4BD7FC219885
given name	Agnès
instance of	wds:Q42224319-1A182155-E827-40E1-AEE2-73E1462D8468
instance of	Homo sapiens
occupation	wds:Q42224319-51C467A0-7998-4E13-81DF-9CFB90F99941 wds:Q42224319-fcfe2120-44e7-3a20-5eb4-4f6b275f72d2
languages spoken, written or signed	wds:Q42224319-85B0CBFD-4A9D-41A7-9975-65E49D156068
sex or gender	wds:Q42224319-EC185EBC-2DF4-4AB0-80C7-462B0FCE3F00
ISNI	wds:Q42224319-C77894A6-4160-4BB8-8322-DE32502644E3
VIAF ID	wds:Q42224319-7108672D-E7F2-4A30-8F26-07A8E3204319
IdRef ID	wds:Q42224319-2D93DBB7-A29B-45B9-90EB-CCF3963BC303
on focus list of Wikimedia project	wds:Q42224319-FC0373C5-1BDE-4294-8731-82F4272BD8EF
date of birth	wds:Q42224319-4C5999B6-2E81-4AF9-9F1A-1C4311F4AEE9
educated at	wds:Q42224319-C2B30C44-AA8D-4775-80E9-5C64FD46FA81
family name	wds:Q42224319-24a77b35-4037-c299-f822-654d75dec20a
WorldCat Identities ID (superseded)	wds:Q42224319-B8897476-307D-4E72-B360-C6E2E248C604
VIAF ID	http://viaf.org/viaf/193957287
IdRef ID	http://www.idref.fr/103218351/id
occupation	hematologist researcher
languages spoken, written or signed	French
sex or gender	female organism
ISNI	0000000431115038
VIAF ID	193957287
IdRef ID	103218351
on focus list of Wikimedia project	WikiProject COVID-19
date of birth	1950-01-01 00:00:00Z (xsd:dateTime)
educated at	Washington University in St. Louis
family name	Veyradier
WorldCat Identities ID (superseded)	viaf-193957287
ORCID iD	wds:Q42224319-C15498B7-8763-49B7-B46B-0CD8826FC4D1
ORCID iD	https://orcid.org/0000-0001-9551-3076
ORCID iD	0000-0001-9551-3076
is owl:sameAs of	Agnès Veyradier
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q42224319
is author of	Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity Thrombotic thrombocytopenic purpura and its diagnosis Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience Causes and risk factors of death in patients with thrombotic microangiopathies. Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children Thrombotic microangiopathies: towards a pathophysiology-based classification Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center Plasma therapy in von Willebrand factor protease deficiency Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience Atypical hemolytic and uremic syndrome associated with von Willebrand factor-cleaving protease (ADAMTS 13) deficiency in children IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura Cancer awareness in atypical thrombotic microangiopathies Clopidogrel induced thrombotic thrombocytopenic purpura Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity Unresponsive thrombotic thrombocytopenic purpura in critically ill adults

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software